Navigation Links
Aflac Incorporated to Webcast 2008 Financial Analysts Briefing
Date:5/7/2008

COLUMBUS, Ga., May 7 /PRNewswire-FirstCall/ -- Aflac Incorporated (NYSE: AFL) announced today that it will webcast its annual Financial Analysts Briefing on May 14 and 15, 2008. Aflac's management will discuss its operations in Japan and in the United States as well as the company's earnings outlook. The schedule of the business meeting webcast is as follows:

Wednesday, May 14, 2008

8:00 p.m. A Strategic Overview of Aflac

Daniel P. Amos, Chairman & CEO, Aflac Incorporated

Thursday, May 15, 2008

8:15 a.m. Opening Remarks

Kenneth S. Janke Jr.

8:30 Introduction to Aflac Japan

Tohru Tonoike

8:50 Japan's Regulatory Environment

Charles D. Lake II

9:10 Aflac Japan Marketing and Sales

Takaaki Matsumoto

9:35 Aflac Japan Bank Channel Sales

Hisayuki Shinkai

10:05 Aflac Japan Administration

Hiroshi Yamauchi

10:25 Aflac Japan Investments

W. Jeremy "Jerry" Jeffery

10:45 Aflac Japan Financial Results

Yuji Arai

11:10 Question & Answer Session

1:05 p.m. Introduction to Aflac U.S.

Paul S. Amos II

1:30 Aflac U.S. Sales

Ronald E. Kirkland

1:45 Aflac U.S. Training

J. Lance Osborne

2:00 Aflac U.S. Internal Operations

Teresa L. White

2:15 Aflac U.S. Investments

Mary Ellen Keim

2:45 Aflac U.S. Financial Results

Ralph A. Rogers Jr.

3:10 Product Pricing and Reserving

Susan R. Blanck

3:30 Aflac Incorporated Overview

Kriss Cloninger III

3:55 Question & Answer Session

The presentations, which include the slides, will be available via webcast. If you would like to sign up for the webcast, you may do so by visiting aflac.com and clicking on the Investors page. You will need to register for the event, so please allow yourself five to seven minutes to sign up prior to the scheduled start time. An archive of the presentations will be available on aflac.com for two weeks beginning on May 15 at 5:00 p.m.

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash where it is needed most when a life-interrupting medical event causes financial challenges. Aflac is the number one provider of guaranteed-renewable insurance in the United States and the number one insurance company in terms of individual insurance policies in force in Japan. Our insurance products provide protection to more than 40 million people worldwide. Aflac has been included in Fortune magazine's listing of America's Most Admired Companies for seven years and in Fortune magazine's list of the 100 Best Companies to Work For in America for ten consecutive years. Aflac has also been recognized three times by both Fortune magazine's listing of the Top 50 Employers for Minorities and Working Mother magazine's listing of the 100 Best Companies for Working Mothers. Aflac Incorporated is a Fortune 500 company listed on the New York Stock Exchange under the symbol AFL. To find out more about Aflac, visit aflac.com .

(Logo: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO )

Analyst and investor contact -- Kenneth S. Janke Jr., 800.235.2667 -- option 3, FAX: 706.324.6330, or kjanke@aflac.com

Media contact - Laura Kane, 706.596.3493, FAX: 706.320.2288, or lkane@aflac.com


'/>"/>
SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Aflac CEO Funds Breast Cancer Symposium in Honor of Companys African-American Female Employees
2. Aflac Shareholders Have Their Say-on-Pay,
3. Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend
4. Aflac Incorporated To Release First Quarter Results on April 23, 2008
5. Aflac Named Among the 50 Best Companies for Supplier Diversity
6. Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta
7. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
8. Training Magazine Applauds Aflacs Employee Learning Programs
9. Aflac Incorporated Announces Fourth Quarter Results
10. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
11. Aflac to Sponsor Iron Girl
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... MO (PRWEB) , ... September 26, 2017 , ... ... agreement for patient scales with Premier Inc. Effective October 1, 2017, the new ... and terms pre-negotiated by Premier for patient scales. , “DETECTO is pleased to ...
(Date:9/26/2017)... ... ... the Millennium”: a gripping take on how the author used personal experience to strengthen ... and do not affect daily choices. It shows how to act like the heirs ... are chosen. “How to Live in the Millennium” is the creation of published author, ...
(Date:9/26/2017)... ... ... “The Ballad of Cowboy Justin”: a charming tale of a brave cowboy who ... creation of published author, Leah Westbrook, a wife and mother who loves to spend ... a delightful tale about a young brave cowboy, Cowboy Justin, who saves the town ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Childhood Memories of a Virginia Wanderer”: ... and help them relive their own youth. “Childhood Memories of a Virginia Wanderer” is ... US Navy for nine years. He received his BS from Idaho State University ...
(Date:9/26/2017)... ... September 26, 2017 , ... “The Tour Guide”: is the life story of the ... creation of published author, David Alexander Stark, is an adventure tour guide and the subject ... around to the back to confront fifteen shocked faces. I played it off as a ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: